Live Breaking News & Updates on Soin therapeutics inc

Stay updated with breaking news from Soin therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Soin Therapeutics Completes Formulation Development of Novel Low Dose Naltrexone Tablet to Treat Complex Regional Pain Syndrome

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Ohio , United-states , Dayton , Amol-soin , Soin-therapeutics-inc , Complex-regional-pain-syndrome , Soin-therapeutics , Health , Pr-newswire ,

Soin Therapeutics Completes Formulation Development of Novel Low Dose Naltrexone Tablet to Treat Complex Regional Pain Syndrome

/PRNewswire/ -- Soin Therapeutics, a biotechnology company based in Dayton, OH, has completed the formulation development work of their novel, proprietary low...

United-states , Ohio , Dayton , Amol-soin , Soin-therapeutics-inc , Soin-therapeutics , Complex-regional-pain-syndrome , Health-care-amp-hospitals- , Medical-pharmaceuticals- , Biotechnology- , New-products-amp-services- ,

FDA Grants Orphan Drug Status to Soin Therapeutics for Low Dose Naltrexone (LDN) to Treat Complex Regional Pain Syndrome (CRPS)

FDA Grants Orphan Drug Status to Soin Therapeutics for Low Dose Naltrexone (LDN) to Treat Complex Regional Pain Syndrome (CRPS)
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Ohio , United-states , Dayton , American , Amol-soin , Soin-therapeutics-inc , American-society-of-interventional-pain-physicians , Regional-pain-syndrome , Orphan-status , Dose-naltrexone , Soin-therapeutics , Investigational-new-drug